Literature DB >> 22814021

Analysis of the role of Nrf2 in the expression of liver proteins in mice using two-dimensional gel-based proteomics.

Azman Abdullah1, Neil R Kitteringham, Rosalind E Jenkins, Christopher Goldring, Larry Higgins, Masayuki Yamamoto, John Hayes, B Kevin Park.   

Abstract

BACKGROUND: The transcription factor Nrf2 regulates expression of multiple cellular defence proteins through the antioxidant response element (ARE). Nrf2-deficient mice (Nrf2(-/-)) are highly susceptible to xenobiotic-mediated toxicity, but it is not known whether this reflects low basal expression or reduced inducibility of Nrf2-regulated genes in response to chemical insults.
METHODS: Wild type and Nrf2(-/-) mice were fed diet supplemented with the established Nrf2 inducer butylated hydroxyanisole (BHA) [0.5% (w/w)] for 14 days. To define the range of Nrf2-regulated proteins, both basally and following exposure to BHA, a comparison of the liver proteomes of Nrf2(-/-) and wild type mice was conducted. The two-dimensional gel electrophoresis (2-DE) technique and MALDI mass spectrometry were utilized in the attempt to define Nrf2-regulated proteins.
RESULTS: Overall, 24 proteins were identified, which were regulated either basally (3 proteins), inducibly (16 proteins), or both (5 proteins). These included several well-established Nrf2-driven gene products e.g., aldo-keto reductase and glutathione transferases. Multiple consensus ARE/ARE-like sequences were found in the Nrf2-regulated genes.
CONCLUSIONS: This study confirms the central role of Nrf2 in the induction of multiple defense proteins as well as its control in the constitutive expression of certain proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814021     DOI: 10.1016/s1734-1140(12)70863-0

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  14 in total

1.  Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.

Authors:  Raju Khatri; Preeti Shah; Rupa Guha; Feyruz V Rassool; Alan E Tomkinson; Angela Brodie; Anil K Jaiswal
Journal:  Mol Cancer Ther       Date:  2015-05-14       Impact factor: 6.261

Review 2.  Mitochondrial biology in airway pathogenesis and the role of NRF2.

Authors:  Hye-Youn Cho; Steven R Kleeberger
Journal:  Arch Pharm Res       Date:  2019-09-04       Impact factor: 4.946

3.  WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes.

Authors:  Patricia Rada; Ana I Rojo; Anika Offergeld; Gui Jie Feng; Juan P Velasco-Martín; José Manuel González-Sancho; Ángela M Valverde; Trevor Dale; Javier Regadera; Antonio Cuadrado
Journal:  Antioxid Redox Signal       Date:  2014-12-09       Impact factor: 8.401

Review 4.  Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.

Authors:  Shengnan Liu; Jingbo Pi; Qiang Zhang
Journal:  Redox Biol       Date:  2022-06-30       Impact factor: 10.787

5.  Loss of NRF2 accelerates cognitive decline, exacerbates mitochondrial dysfunction, and is required for the cognitive enhancing effects of Centella asiatica during aging.

Authors:  Jonathan A Zweig; Mikah S Brandes; Barbara H Brumbach; Maya Caruso; Kirsten M Wright; Joseph F Quinn; Amala Soumyanath; Nora E Gray
Journal:  Neurobiol Aging       Date:  2020-12-25       Impact factor: 4.673

Review 6.  The emerging role of Nrf2 in mitochondrial function.

Authors:  Albena T Dinkova-Kostova; Andrey Y Abramov
Journal:  Free Radic Biol Med       Date:  2015-05-11       Impact factor: 7.376

Review 7.  Nrf2, the Master Regulator of Anti-Oxidative Responses.

Authors:  Sandra Vomund; Anne Schäfer; Michael J Parnham; Bernhard Brüne; Andreas von Knethen
Journal:  Int J Mol Sci       Date:  2017-12-20       Impact factor: 5.923

Review 8.  Nrf2 Signaling and the Slowed Aging Phenotype: Evidence from Long-Lived Models.

Authors:  Danielle R Bruns; Joshua C Drake; Laurie M Biela; Frederick F Peelor; Benjamin F Miller; Karyn L Hamilton
Journal:  Oxid Med Cell Longev       Date:  2015-10-25       Impact factor: 6.543

9.  NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer.

Authors:  Akhileshwar Namani; Qin Qin Cui; Yihe Wu; Hongyan Wang; Xiu Jun Wang; Xiuwen Tang
Journal:  Oncotarget       Date:  2017-07-18

10.  NRF2 as a Therapeutic Target in Neurodegenerative Diseases.

Authors:  Mikah S Brandes; Nora E Gray
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.